Year 12 Biology Module 6 · IQ2 ⏱ ~35 min Practice bank · 3 Short Answer Lesson 9 of 18

Ethics and Social Implications of Biotechnology

In 1999, Ingo Potrykus (ETH Zürich) and Peter Beyer (University of Freiburg) published in Science their Golden Rice, engineered with daffodil and soil bacterium genes to express β-carotene (provitamin A). A 250 g serving provides 100% of a child's daily vitamin A requirement. WHO 2022 data show vitamin A deficiency affects 190 million children under 5 globally, causing 350,000 to go blind annually. Yet Golden Rice remains controversial. Usefulness does not automatically resolve ethical complexity.

Today's hook: In 1999, Ingo Potrykus at ETH Zürich and Peter Beyer at the University of Freiburg published in Science a genetically modified rice that produces β-carotene, provitamin A, using two inserted genes. A single 250 g serving could cover 100% of a child's daily vitamin A need. WHO data show 350,000 children go blind from vitamin A deficiency every year. Yet activists destroyed trial fields, and Golden Rice still has not reached most affected children 25 years later. If a biotechnology could prevent blindness in 350,000 children annually, why would anyone oppose it?
0/5TASKS
Worksheets

Practise this lesson

Four printable worksheets that build from the foundations up to exam-style questions, start at whatever level suits you.

Ethical considerations in biotechnology

Ethical considerations in biotechnology, benefit, welfare, ownership, equity and environment.

Evaluate a Claim
warm-up

A claim is made: If a biotechnology increases food production or medical benefit, then it is ethically justified.

Write whether you agree or disagree, then name at least two other factors that should be considered before judging the biotechnology as ethically acceptable.

Learning Intentions
goals

Know

  • Biotechnology affects many stakeholder groups differently.
  • Plant and animal examples raise distinct ethical issues.
  • Benefit alone is not enough for full ethical evaluation.

Understand

  • Ethical analysis must include welfare, ownership, equity and environment.
  • Different stakeholders may judge the same biotechnology differently.
  • Social implications can be positive, negative or mixed.

Apply

  • Use stakeholder analysis instead of a simple pros-and-cons list.
  • Evaluate plant and animal biotechnology with precise criteria.
  • Write balanced, evidence-led HSC judgements.
Scan these before reading
vocab
StakeholderA person or group affected by a biotechnology, such as farmers, consumers, companies, researchers, regulators or communities.
Ethical useUse judged in relation to values such as fairness, welfare, harm, autonomy, environmental responsibility and justice.
Food securityReliable access to sufficient, safe and nutritious food.
EquityFairness in access to benefits, risks and decision-making power.
OwnershipControl of technology, products, patents or biological material.
Animal welfareConsideration of suffering, stress and quality of life in animals used or altered by biotechnology.
Key Point
"It works" or "it boosts yield" is not an ethical conclusion. A complete evaluation asks who benefits, who bears the risk, and whether welfare, ownership, equity and environmental effects make that distribution fair.
1
Biotechnology Should Be Analysed Through Stakeholder Perspectives
+5 XP

Decision lens · who is affected and how

Golden Rice, published by Potrykus and Beyer in 1999 Science, could prevent blindness in 350,000 children annually, a clear humanitarian benefit valued by nutritional scientists and public health agencies. But seed patent holders see it as a commercial threat; organic farming advocates see it as unwanted genetic contamination of traditional crops; and affected communities in Asia were not always consulted about deployment in their food systems. The same rice variety looks different depending on where you stand.

Instead of a flat pros-and-cons list, map the groups who gain, the groups who carry risk, and the values each group holds. This produces a more balanced and defensible HSC judgement.

Farmers and producers

May value yield, resistance, reliability and profit, but may also face dependence on patented technologies.

Consumers and patients

May value affordability, safety and medical benefit, but may raise concerns about transparency, consent or long-term effects.

Companies and researchers

May drive innovation and product development, but raise questions about ownership, patents and control of access.

Governments and regulators

Must balance innovation, safety, public trust, biodiversity protection and social fairness.

Evaluating biotechnology ethically requires stakeholder analysis, mapping who benefits, who bears risk, and which values each group holds, rather than a simple pros-and-cons list, because different groups (farmers, consumers, companies, regulators) can judge the same technology very differently.

Pause, copy the highlighted approach into your book before moving on.

What is a stakeholder in the context of biotechnology?

2
Plant Biotechnology Raises Food-Security and Environmental Trade-Offs
+5 XP

Plant example · benefit weighed against ownership and ecology

We just saw that ethical evaluation requires stakeholder analysis rather than simple pros and cons. That raises a question: how does that framework apply specifically to plant biotechnologies? This card answers it → food security vs ownership and ecology.

Biotechnology in plants may improve crop yield, pest resistance, drought tolerance or nutritional quality. These benefits can support food security and reduce some agricultural losses. However, ethical analysis must also consider seed ownership, dependence on purchased technologies, effects on farmer choice, and possible ecological impacts if crop systems become more uniform or if surrounding ecosystems are affected.

Possible benefits

  • Improved productivity and food supply.
  • Reduced crop loss from pests or disease.
  • Potential nutritional improvement.

Possible concerns

  • Farmer dependence on patented seed systems.
  • Reduced crop diversity if a few varieties dominate.
  • Environmental effects beyond the target crop system.
Plant Case
GM crop debates are not just about whether the plant works. They also involve who controls the seed, who benefits economically, and what happens to local biodiversity and agricultural independence.

Plant biotechnology may improve crop yield, pest resistance and nutrition, but ethical analysis must also consider seed ownership, farmer dependence on patented technologies, reduced crop diversity, and possible ecological impacts on surrounding ecosystems.

Add the highlighted point to your notes before the check below.

GM crop debates are only about whether the modified plant works biologically.

Germ-line gene editing raises ethical concerns because genetic changes can be inherited by future generations.

All biotechnological applications have been universally accepted by all cultures and societies.

Interactive · Ethics Decision Tree
3
Animal Biotechnology Adds Major Welfare and Consent Concerns
+5 XP

Animal example · welfare sharpens the analysis

We just saw that plant biotechnology involves ownership and ecological trade-offs. That raises a question: does animal biotechnology raise additional ethical concerns? This card answers it → animal welfare as a key dimension.

Biotechnology in animals may aim to improve disease resistance, productivity or biomedical usefulness. Ethical concerns here often become sharper because animal welfare is directly involved. Even if a biotechnology increases efficiency, it may still be challenged if it increases suffering, stress, deformity or confinement.

Potential justifications

  • Better disease resistance in livestock.
  • Medical research or therapeutic production.
  • Possible gains in productivity.

Key ethical questions

  • Does the animal experience harm or distress?
  • Is the gain mainly economic or genuinely necessary?
  • How much manipulation is ethically justified?

Animal biotechnology therefore often requires stronger ethical scrutiny than a purely production-focused discussion would suggest.

Animal biotechnology introduces welfare concerns as a central ethical issue, even if a technology increases efficiency, it can be challenged if it causes suffering, stress, deformity or confinement, and these welfare questions require stronger scrutiny than productivity arguments alone.

Pause, write the highlighted principle into your book.

Which issue becomes especially important when evaluating biotechnology in animals?

4
Strong HSC Evaluation Balances Benefit, Harm, Fairness and Environmental Effect
+5 XP

Ethical framework · the questions a Band 6 answer asks

We just saw that animal welfare sharpens ethical analysis beyond productivity. That raises a question: what does a complete evaluation framework actually look like? This card answers it → the five-question ethical framework.

Good analysis moves beyond pros and cons. It weighs who benefits, who bears risk, and whether the distribution of benefit and harm is fair. It also asks whether the technology changes social dependence, access or environmental sustainability.

Questions to ask

  • What problem is the biotechnology trying to solve?
  • Who benefits most?
  • Who carries the main risk or cost?
  • Are welfare or environmental harms justified?
  • Is access equitable or controlled by ownership structures?

This lesson sets up the rest of IQ2. Later lessons will extend these judgements into biodiversity change and future directions, but the ethical method starts here.

A strong HSC biotechnology evaluation asks: what problem is solved, who benefits most, who bears risk or cost, are welfare or environmental harms justified, and is access equitable, this five-question framework produces balanced, defensible judgements.

Pause, copy the highlighted framework into your notes before continuing.

A strong evaluation weighs who benefits against who bears the main risk or _____.

Activity 1
ApplyBand 4

Stakeholder Map

For one plant biotechnology and one animal biotechnology, list the stakeholders affected and what each one most values or worries about.

Activity 2
EvaluateBand 5

Strengthen the Judgement

Rewrite this weak judgement into a balanced, stakeholder-aware one: "This biotechnology is good because it increases production."

Cross-lesson links: L08 surveyed biotechnology broadly. L09 evaluates specific technologies against a benefits/risks framework, Golden Rice is the paradigm case for HSC evaluate questions: genuine humanitarian benefit vs genuine ecological, intellectual property, and cultural concerns.
PRIORITY MISCONCEPTIONS
Priority Misconceptions
✗ If a biotechnology is scientifically safe, there are no other reasons to restrict it.
✓ Scientific safety is one consideration, but ethical analysis also addresses equity of access, community consent, ecological risk, ownership of genetic resources and cultural values. A technology can be scientifically sound and still raise legitimate ethical concerns that justify regulation.

Core biological claim

  • Ethical use of biotechnology depends on more than biological effectiveness.

Mechanism or process

  • Biotechnology should be analysed through stakeholder perspectives, considering food security, welfare, ownership, equity and environmental effect.

Common exam error

  • Reducing ethical analysis to a simple list of benefits without discussing who benefits, who pays and what trade-offs exist.

Evaluative sentence starter

  • "Although the biotechnology may improve productivity or medical outcomes, its ethical acceptability depends on stakeholder impact, fairness, welfare and environmental consequences."
Interactive Tool, Gene Pools & Biotechnology Open fullscreen ↗
Two of these statements about gene pools are TRUE. Find the LIE.
01
Multiple Choice
+5 XP

A fresh set drawn from this lesson's question bank, feedback shown immediately. +5 XP per correct · +25 XP all correct

Pick your answer, then rate your confidence, that tells the system what to drill next.

02
Short Answer, 12 marks
+5 XP

UnderstandBand 3(3 marks) 1. Explain why stakeholder analysis is useful when judging biotechnology.

AnalyseBand 4(4 marks) 2. Compare the main ethical issues raised by plant biotechnology and animal biotechnology.

EvaluateBand 5–6(5 marks) 3. Evaluate the claim: If biotechnology improves food security, that benefit outweighs all other concerns.

Show all answers

Multiple choice

MC answers and full explanations are shown inline as you complete each question. Use the retry button to attempt a fresh set from the lesson bank.

Activity 1, Stakeholder map

Plant example answers should include groups such as farmers, consumers, seed companies, regulators and ecosystems. Animal example answers should include groups such as producers, consumers, researchers, regulators, animal welfare advocates and the animals themselves.

Activity 2, Strengthen the judgement

A stronger judgement would say something like: "Although the biotechnology increases production, its ethical value depends on whether the benefits are shared fairly, whether welfare or environmental harm occurs, and whether ownership structures create dependence or unequal access."

Short Answer Model Responses

Q1 (3 marks): Stakeholder analysis is useful because biotechnology affects different groups in different ways [1]. One group may benefit economically or medically while another may carry more risk or cost [1]. Therefore stakeholder analysis helps produce a more balanced ethical judgement [1].

Q2 (4 marks): Plant biotechnology often raises issues such as food security, ownership of seed technologies and environmental impact [1]. Animal biotechnology also raises those issues in some cases, but adds stronger direct concern about animal welfare and suffering [1]. A similarity is that both require analysis of benefit, risk and fairness [1]. A key difference is that animal biotechnology often intensifies welfare concerns more directly [1].

Q3 (5 marks): Improving food security is an important benefit because reliable food supply matters socially and economically [1]. However, that benefit does not automatically outweigh all other concerns [1]. Ethical judgement must also consider ownership, equity, environmental impact and, in some cases, welfare [1]. Different stakeholders may experience the same biotechnology differently [1]. Therefore food security is a strong factor, but it should be weighed alongside other ethical and social consequences rather than treated as an automatic override [1].

RAPID REVIEW
The big ideas in four tiles

Stakeholders

Different groups may judge the same biotechnology differently.

Plant cases

Often focus on food security, ownership and environment.

Animal cases

Add strong welfare concerns about suffering and stress.

Exam trap

Calling a biotechnology ethical just because it works biologically.

Test yourself against the clock
boss

Rapid-fire questions on stakeholders, plant and animal ethics, and balanced evaluation. Beat the boss to bank a tier, gold (perfect + fast), silver (80%+), or bronze (cleared).

How did your thinking change?

Return to Golden Rice, published by Ingo Potrykus and Peter Beyer in 1999 Science. You should now be able to explain why the ability to prevent 350,000 cases of childhood blindness annually (WHO 2022) does not automatically justify deploying the technology: farmers in vitamin-A-deficient regions were not meaningfully consulted; patents held by Syngenta and others raised equity concerns; and organic agriculture movements raised contamination fears. Ethical judgement requires weighing humanitarian benefit against stakeholder impact, equity, environmental risk, and consent, and these do not always point the same direction.